Literature DB >> 20708304

Chemometric modeling, docking and in silico design of triazolopyrimidine-based dihydroorotate dehydrogenase inhibitors as antimalarials.

Probir Kumar Ojha1, Kunal Roy.   

Abstract

In the present work, QSAR and molecular docking studies have been performed on triazolopyrimidine-based dihydroorotate dehydrogenase (DHODH) inhibitors as antimalarial agents. The QSAR studies have been carried out using classical QSAR (physicochemical) approach using linear free energy related (LFER) model and molecular shape analysis using shape, spatial, electronic, thermodynamic and structural descriptors. Docking studies suggest that the 2-methyltriazolopyrimidine ring interacts with some polar and some nonpolar amino acids whereas the substituted phenyl ring binds with a hydrophobic pocket of the enzyme formed by some nonpolar amino acid residues. According to QSAR and molecular docking studies, we have designed some new compounds which showed good in silico predicted activity as per the developed QSAR models. Copyright (c) 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20708304     DOI: 10.1016/j.ejmech.2010.07.034

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  8 in total

1.  Antibacterial activities of sulfamethoxazolyl-azo-phenols and their Cu(II) complexes along with molecular docking properties.

Authors:  Nilima Sahu; Sudipa Mondal; Nayim Sepay; Suvroma Gupta; Elena Torres-Lopez; Shinnosuke Tanaka; Takashiro Akitsu; Chittaranjan Sinha
Journal:  J Biol Inorg Chem       Date:  2017-04-28       Impact factor: 3.358

2.  3D-QSAR studies of triazolopyrimidine derivatives of Plasmodium falciparum dihydroorotate dehydrogenase inhibitors using a combination of molecular dynamics, docking, and genetic algorithm-based methods.

Authors:  Priyanka Shah; Sumit Kumar; Sunita Tiwari; Mohammad Imran Siddiqi
Journal:  J Chem Biol       Date:  2012-02-05

3.  Synthesis, structure and biological evaluation of ruthenium(III) complexes of triazolopyrimidines with anticancer properties.

Authors:  Marzena Fandzloch; Liliana Dobrzańska; Tomasz Jędrzejewski; Julia Jezierska; Joanna Wiśniewska; Iwona Łakomska
Journal:  J Biol Inorg Chem       Date:  2019-11-18       Impact factor: 3.358

4.  Site Specific Interaction Between TiO2 Nanoparticles and Phenanthrimidazole-A First Principles Quantum Mechanical Study.

Authors:  Jayaraman Jayabharathi; Periyasamy Ramanathan; Chockalingam Karunakaran; Venugopal Thanikachalam
Journal:  J Fluoresc       Date:  2015-06-26       Impact factor: 2.217

5.  Expanding the Antimalarial Drug Arsenal-Now, But How?

Authors:  Brian T Grimberg; Rajeev K Mehlotra
Journal:  Pharmaceuticals (Basel)       Date:  2011-05-01

6.  3D-QSAR studies on a series of dihydroorotate dehydrogenase inhibitors: analogues of the active metabolite of leflunomide.

Authors:  Shun-Lai Li; Mao-Yu He; Hong-Guang Du
Journal:  Int J Mol Sci       Date:  2011-05-10       Impact factor: 5.923

7.  Discovery of potent, novel, non-toxic anti-malarial compounds via quantum modelling, virtual screening and in vitro experimental validation.

Authors:  David J Sullivan; Nikola Kaludov; Martin N Martinov
Journal:  Malar J       Date:  2011-09-20       Impact factor: 2.979

8.  Development of a human dihydroorotate dehydrogenase (hDHODH) pharma-similarity index approach with scaffold-hopping strategy for the design of novel potential inhibitors.

Authors:  Kuei-Chung Shih; Chi-Ching Lee; Chi-Neu Tsai; Yu-Shan Lin; Chuan-Yi Tang
Journal:  PLoS One       Date:  2014-02-04       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.